| Literature DB >> 27053247 |
Xu Shi1,2, Shuang Lv1, Xia He1, Xiaomei Liu1, Meiyu Sun1, Meiying Li1, Guangfan Chi1, Yulin Li3.
Abstract
Due to the limitations of organ donors and immune rejection in severe liver diseases, stem cell-based therapy presents a promising application for tissue repair and regeneration. As a novel cell source, mesenchymal stem cells separated from human hair follicles (HF-MSCs) are convenient to obtain and have no age limit. To date, the differentiation of HF-MSCs into hepatocytes has not been reported. In this study, we explored whether HF-MSCs and HF-MSC-derived-induced pluripotent stem cells (HF-iPS) could differentiate into hepatocytes in vitro. Flow cytometry, Oil Red O stain and Alizarin Red stain were used to identify the characteristics of HF-MSCs. The expression of liver-specific gene was detected by immunofluorescence and Quantitative Polymerase Chain Reaction. Periodic Acid-Schiff stain, Indocyanine Green stain and Low-Density Lipoprotein stain were performed to evaluate the functions of induced hepatocyte-like cells (HLCs). HF-MSCs were unable to differentiate into HLCs using previously reported procedures for MSCs from other tissues. However, HF-iPS efficiently induced the generation of HLCs that expressed hepatocyte markers and drug metabolism-related genes. HF-iPS can be used as novel and alternative cellular tools for inducing hepatocytes in vitro, simultaneously benefiting from utilizing HF-MSCs as a noninvasive and convenient cell source for reprogramming.Entities:
Keywords: End-stage liver disease; Hair follicle mesenchymal stem cells; Hepatocytes; Induced pluripotent stem cells; Multipotential differentiation
Mesh:
Substances:
Year: 2016 PMID: 27053247 DOI: 10.1007/s00441-016-2399-5
Source DB: PubMed Journal: Cell Tissue Res ISSN: 0302-766X Impact factor: 5.249